PATHOLOGIC PROCESSES
Clinical trials for PATHOLOGIC PROCESSES explained in plain language.
Never miss a new study
Get alerted when new PATHOLOGIC PROCESSES trials appear
Sign up with your email to follow new studies for PATHOLOGIC PROCESSES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cancer pill tested in patients who ran out of options
Disease control CompletedThis first-in-human study tested a new oral medication called MRX-2843 in adults with advanced solid tumors that had returned or stopped responding to standard treatments. The main goals were to find the highest safe dose and understand how the drug moves through the body. Resear…
Matched conditions: PATHOLOGIC PROCESSES
Phase: PHASE1 • Sponsor: Meryx, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
Stem cell shots aim to save limbs after amputation
Disease control CompletedThis early-stage study tested whether injecting donor stem cells into the leg muscles of patients about to have a major amputation could help prevent serious wound complications after surgery. The main goal was to check if the injections were safe. Researchers also wanted to see …
Matched conditions: PATHOLOGIC PROCESSES
Phase: PHASE1 • Sponsor: Indiana University • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
Scientists infect volunteers to test new malaria pill
Disease control CompletedThis early-stage study tested a new oral drug, MMV367, for malaria. Researchers deliberately infected 12 healthy adult volunteers with malaria parasites to see how the drug is processed by the body and how well it kills the parasites. The main goal was to understand the relations…
Matched conditions: PATHOLOGIC PROCESSES
Phase: PHASE1 • Sponsor: Medicines for Malaria Venture • Aim: Disease control
Last updated Mar 16, 2026 15:25 UTC
-
Scientists probe hidden blood clues in HIV patients
Knowledge-focused CompletedThis study aimed to better understand certain markers in the blood related to inflammation and clotting in people with HIV. Researchers collected blood samples from 310 HIV-positive adults and healthy volunteers to see how these markers might be linked to risks like heart disease…
Matched conditions: PATHOLOGIC PROCESSES
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Mar 20, 2026 14:47 UTC